Webinar featuring our Formulation Scientist, Sydney Marchando, MS. & Nick Boylan, Ph.D., Director of Nucleic Acid Delivery.
Glioblastoma (GBM) is a malignant brain tumor that remains among the most formidable cancers.Despite a well-established standard of care of maximal surgical resection followed by radiotherapy plus concomitant temozolomide (TMZ), median survival remains approximately 15 months.
Our team presents the process of Nanosuspension for the novel Indirubin, for the potential treatment of Glioblastoma.
Phosphorex's director of nucleic delivery presents on Nanoparticles for the delivery of ASO to the CNS
In collaboration with Brown University, Phosphorex presents on the use the nanoparticle formulation, to enable Systematic Delivery of Tx Agent to treat GBM
Partnership Opportunities in Drug Delivery (PODD) conference explores the value of drug delivery technologies both to patients and pharma with a focus on the future direction of the field.